acyclovir
Generic: acyclovir
Labeler: camber pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
camber pharmaceuticals, inc.
Dosage Form
SUSPENSION
Routes
Active Ingredients
acyclovir 200 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
31722-681
Product ID
31722-681_e87a8107-f6d9-5bf2-e053-2a95a90afc80
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA215669
Listing Expiration
2026-12-31
Marketing Start
2022-07-01
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
31722681
Hyphenated Format
31722-681
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA215669 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/5mL
Packaging
- 473 mL in 1 BOTTLE (31722-681-47)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "e87a8107-f6d9-5bf2-e053-2a95a90afc80", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0331722681476"], "unii": ["X4HES1O11F"], "rxcui": ["307730"], "spl_set_id": ["2ca1395f-96b4-4543-8eed-bd07c62bbc7c"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (31722-681-47)", "package_ndc": "31722-681-47", "marketing_start_date": "20220701"}], "brand_name": "Acyclovir", "product_id": "31722-681_e87a8107-f6d9-5bf2-e053-2a95a90afc80", "dosage_form": "SUSPENSION", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "31722-681", "generic_name": "Acyclovir", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/5mL"}], "application_number": "ANDA215669", "marketing_category": "ANDA", "marketing_start_date": "20220701", "listing_expiration_date": "20261231"}